IntraHealth International

Global Perinatal Software Market Set to Surge to $254 Million by 2030, Driven by Advanced Technology Adoption

Retrieved on: 
Thursday, September 21, 2023
Communication, Epic Systems, Pregnancy, OBIX, McKesson Corporation, Data analysis, Health care, Personal Data Privacy and Security Act of 2009, Privacy, Personalized medicine, MEA, Child care, Security, Compound annual growth rate, Documentation, Cerner, Patient, Carestream Health, Machine learning, General Electric Company, Siemens, IntraHealth International, MEDITECH, Artificial intelligence, Diagnosis, Region, Deployment, Vidius perigenes, Medical device, Medical imaging, Application

The global perinatal software market, which was valued at $97.7 million in 2022, is projected to grow to $254 million by 2030 at a Compound Annual Growth Rate (CAGR) of 11.2%.

Key Points: 
  • The global perinatal software market, which was valued at $97.7 million in 2022, is projected to grow to $254 million by 2030 at a Compound Annual Growth Rate (CAGR) of 11.2%.
  • The perinatal software segment is an essential part of healthcare software designed for use during the perinatal period, encompassing pregnancy, childbirth, and the postpartum period.
  • Product: The perinatal software market is segmented into integrated and standalone software.
  • Lack of Standardization and Interoperability: The perinatal software market faces challenges related to the lack of standardization and interoperability between different software systems.

New urban health 'accelerator' aims to transform cardiovascular population health globally

Retrieved on: 
Monday, May 22, 2023
Blood pressure, Workforce, Male, Cardiovascular disease, CV, Stroke, Public, Workplace, World Health Assembly, Health, Splenic infarction, Hypertension, Death, Risk, Novartis Foundation, IntraHealth International, Accelerator, City, WHO, Paulo, World Health Organization, Pharmaceutical industry

The CARDIO4Cities Accelerator by Novartis Foundation and IntraHealth International aims to replicate the successful CARDIO4Cities approach in 30 major cities within three years to transform cardiovascular population health and equity globally.

Key Points: 
  • The CARDIO4Cities Accelerator by Novartis Foundation and IntraHealth International aims to replicate the successful CARDIO4Cities approach in 30 major cities within three years to transform cardiovascular population health and equity globally.
  • Experts say public-private partnerships are key to address the growing burden of cardiovascular disease, the world's leading cause of death, according to the World Health Organization (WHO)1.
  • The accelerator aims to replicate CARDIO4Cities, the cardiovascular (CV) population health approach pioneered and validated by the Novartis Foundation, in 30 major cities within the next three years.
  • As a neutral broker between city governments, health experts, industry, implementing partners, funders and investors, the accelerator pledges the global community to direct action and funding toward transforming CV population health and equity.

New urban health 'accelerator' aims to transform cardiovascular population health globally

Retrieved on: 
Monday, May 22, 2023
Blood pressure, Workforce, Male, Cardiovascular disease, CV, Stroke, Public, Workplace, World Health Assembly, Health, Splenic infarction, Hypertension, Death, Risk, Novartis Foundation, IntraHealth International, Accelerator, City, WHO, Paulo, World Health Organization, Pharmaceutical industry

The CARDIO4Cities Accelerator by Novartis Foundation and IntraHealth International aims to replicate the successful CARDIO4Cities approach in 30 major cities within three years to transform cardiovascular population health and equity globally.

Key Points: 
  • The CARDIO4Cities Accelerator by Novartis Foundation and IntraHealth International aims to replicate the successful CARDIO4Cities approach in 30 major cities within three years to transform cardiovascular population health and equity globally.
  • Experts say public-private partnerships are key to address the growing burden of cardiovascular disease, the world's leading cause of death, according to the World Health Organization (WHO)1.
  • The accelerator aims to replicate CARDIO4Cities, the cardiovascular (CV) population health approach pioneered and validated by the Novartis Foundation, in 30 major cities within the next three years.
  • As a neutral broker between city governments, health experts, industry, implementing partners, funders and investors, the accelerator pledges the global community to direct action and funding toward transforming CV population health and equity.

Johnson & Johnson Celebrates COVID-19 Vaccine Science Superheroes

Retrieved on: 
Tuesday, September 28, 2021
Nobel Prize, Paganini Competition, Mentorship, Man, IntraHealth International, Vaccine, Global Health, World Health Organization's response to the COVID-19 pandemic, Biomedicine, Limit cycle, Memory, Therapy, Health, University, Rockefeller University, Multimedia, Beth Israel Deaconess Medical Center, LinkedIn, Heart, Executive Committee, COVID-19 vaccine, Environment, Industry, Face, Program, Family, Woman, World, Johnson & Johnson COVID-19 vaccine, AstraZeneca, Science, COVID-19, Johnson & Johnson, View, Health equity, S-1 Executive Committee, NYSE, Award, Biomedical Research, Government, Pharmaceutical industry

"It is a great honor to recognize the work of researchers like Dr. Karik and Dr. Weissman, and all of the COVID-19 vaccine science superheroes who embody the same curiosity, perseverance and commitment to improving human health as Dr. Paul Janssen," said Paul Stoffels, M.D., Vice Chairman of the Executive Committee and Chief Scientific Officer, Johnson & Johnson.

Key Points: 
  • "It is a great honor to recognize the work of researchers like Dr. Karik and Dr. Weissman, and all of the COVID-19 vaccine science superheroes who embody the same curiosity, perseverance and commitment to improving human health as Dr. Paul Janssen," said Paul Stoffels, M.D., Vice Chairman of the Executive Committee and Chief Scientific Officer, Johnson & Johnson.
  • Johnson & Johnson will honor these remarkable scientistsduring a live webcast program "Eureka Moments: Vaccine Science Superheroes" on September 28, 2021 at 11:00 a.m.
  • "Now more than ever, the world needs science to come to the rescue," said Seema Kumar, Global Head, Office of Innovation, Global Health and Scientific Engagement, Johnson & Johnson.
  • The Dr. Paul Janssen Award for Biomedical Research was established by Johnson & Johnson in 2004 to honor the memory of Dr. Paul.

Takeda Selects Four New Partners for Annual Global Corporate Social Responsibility (CSR) Program to Help Strengthen Health Systems in Low- and Middle-Income Countries

Retrieved on: 
Wednesday, September 22, 2021
Philanthropy, Health, Other Philanthropy, General Health, Pharmaceutical, Biotechnology, Knowledge, Health, Mortality, United Nations Humanitarian Response Depot, Hematology, Child, Vaccine, Iwin, Safety, Investment, Health education, Failure, Mark (given name), Public sector, Takeda Pharmaceutical Company, U.S. Securities and Exchange Commission, Refugee, Measles, Disease, CEO, Leadership, Genetics, Pathfinder International, Global, Partnership, SDG, World Food Programme, Woman, Annual report, TSE, WFP, TAK, Acquisition, CSR, Face, R, Pregnancy, Time, Projection, Adoption, Humble Bundle, IntraHealth International, Climate change, Limit cycle, Emergency, Patient, Public–private partnership, Nursing, Logistics, COVID-19, Quality of life, Pharmaceutical industry, Medicine, Birth control, Renewable energy, Risk management

Takeda Pharmaceutical Company Limited ( TSE:4502/NYSE:TAK ) (Takeda) today announced the addition of four partnerships to its Global Corporate Social Responsibility (CSR) Program , which makes long-term commitments to strengthen health systems and improve access to healthcare for all in developing and emerging countries.

Key Points: 
  • Takeda Pharmaceutical Company Limited ( TSE:4502/NYSE:TAK ) (Takeda) today announced the addition of four partnerships to its Global Corporate Social Responsibility (CSR) Program , which makes long-term commitments to strengthen health systems and improve access to healthcare for all in developing and emerging countries.
  • The project will strengthen access to equitable health services, build community resilience to climate shocks and help women forge their own path to a healthier future.
  • Each project addresses strengthening health systems in unique ways and aligns with countries national health needs.
  • In this release, Takeda is sometimes used for convenience where references are made to Takeda and its subsidiaries in general.

Polly Dunford to Lead IntraHealth International as New President and CEO

Retrieved on: 
Friday, February 14, 2020
Chapel Hill-Carrboro, North Carolina, Health in Ghana, Health in Rwanda, Health in Uganda, IntraHealth International, United States Agency for International Development, Intrahealth, Health, Articles, Countries

CHAPEL HILL, N.C., Feb. 14, 2020 /PRNewswire/ --Today, IntraHealth International's board of directors announced Polly Dunford will be IntraHealth's next president and CEO.

Key Points: 
  • CHAPEL HILL, N.C., Feb. 14, 2020 /PRNewswire/ --Today, IntraHealth International's board of directors announced Polly Dunford will be IntraHealth's next president and CEO.
  • Dunford is joining IntraHealth after nearly 20 years of service with the U.S. Agency for International Development (USAID) in Cambodia, Haiti, Jordan, Mozambique, Nigeria and Washington, D.C., most recently as the global director for HIV/AIDS.
  • "I'm delighted to welcome Polly," says Jean Gilson, cochair of the board.
  • Dunford will succeed outgoing president and CEO Pape Gaye, who has been at the helm since 2004.

IntraHealth International CEO Pape Gaye to Transition to President Emeritus in 2020

Retrieved on: 
Wednesday, May 8, 2019
Chapel Hill-Carrboro, North Carolina, Health in Ghana, Health in Rwanda, Health in Uganda, IntraHealth International, Health, Intrahealth

CHAPEL HILL, N.C., May 8, 2019 /PRNewswire/ --IntraHealth International president and CEO Pape Gaye will transition to the role of president emeritus by early 2020.

Key Points: 
  • CHAPEL HILL, N.C., May 8, 2019 /PRNewswire/ --IntraHealth International president and CEO Pape Gaye will transition to the role of president emeritus by early 2020.
  • I look forward to welcoming a new leader and offering my full support as IntraHealth continues to expand its impact.
  • Gaye has led IntraHealth for 14 years, growing its annual revenue from $20 million to over $100 million in that time.
  • I congratulate Pape on his upcoming transition and am very excited to see what this next chapter holds for IntraHealth."

Storytelling Training Leads Frontline Health Workers to Advocate at the Highest Levels of Governance

Retrieved on: 
Tuesday, May 29, 2018
Health, Chapel Hill-Carrboro, North Carolina, Health in Ghana, Health in Rwanda, Health in Uganda, IntraHealth International, Intrahealth Systems Limited, Health professional, Health care, Frontline, Health policy

GENEVA, May 29, 2018 /PRNewswire-USNewswire/ --The firsthand perspectives of frontline health workers are becoming more influential at the highest levels of policymaking, including last week during the 71st World Health Assembly in Geneva, Switzerland.

Key Points: 
  • GENEVA, May 29, 2018 /PRNewswire-USNewswire/ --The firsthand perspectives of frontline health workers are becoming more influential at the highest levels of policymaking, including last week during the 71st World Health Assembly in Geneva, Switzerland.
  • Over the past two years, IntraHealth International and its partners at the Frontline Health Workers Coalition and Medtronic Foundation have trained 11 health workers from Brazil, India, Ireland, South Africa, Uganda, the United States and Zambia to share their accounts of providing health services to underserved communities.
  • Access to such platforms and audiences are helping the health workers influence policies, expand access to high-quality health services in their communities and raise the profile of frontline health workers' impact and the structural barriers they face.
  • IntraHealth and the Frontline Health Workers Coalition urge all advocacy and policymaking bodies to build on this momentum and ensure frontline health workers, patients and other community voices are meaningfully included in global health policy forums and conferences.